Exact Sciences
EXAS
$69.53
Share price
-4.69%
Change (1 day)
46.10%
Change (1 year)
Categories
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.
Earnings for Exact Sciences (EXAS)
Earnings in 2023 (TTM): -$0.43 B
According to Exact Sciences's latest financial reports the company's current earnings (TTM) are -$0.43 B. In 2022 the company made an earning of -$0.62 B an increase over its 2021 earnings that were of -$0.83 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Exact Sciences from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.43 B | -31.67% |
| 2022 | -$0.62 B | -25.35% |
| 2021 | -$0.83 B | 7.23% |
| 2020 | -$0.78 B | 272.02% |
| 2019 | -$0.21 B | 49.89% |
| 2018 | -$0.14 B | 20.68% |
| 2017 | -$0.12 B | -31.81% |
| 2016 | -$0.17 B | 6.1% |
| 2015 | -$0.16 B | 58.38% |
| 2014 | -$100 M | 115.3% |
| 2013 | -$46.45 M | |
| 2011 | -$28.83 M | 143.73% |
| 2010 | -$11.83 M | 27.85% |
| 2009 | -$9.25 M | 0.27% |
| 2008 | -$9.23 M | -20.95% |
| 2007 | -$11.67 M | -13.53% |
| 2006 | -$13.5 M | -10.07% |
| 2005 | -$15.01 M | -21.81% |
| 2004 | -$19.2 M | -33.44% |
| 2003 | -$28.84 M | -6.51% |
| 2002 | -$30.85 M | 17.95% |
| 2001 | -$26.16 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $9.96 B | -2,462.23% | 🇫🇷 France |
 Veracyte VCYT | -$33.65 M | -92.02% | 🇺🇸 USA |
 Antares Pharma ATRS | $65.88 M | -115.62% | 🇺🇸 USA |
 Myriad Genetics MYGN | -$0.27 B | -37.80% | 🇺🇸 USA |
 Biocept
BIOC | -$34.97 M | -91.71% | 🇺🇸 USA |